ARINA-1

DRUG3 trials

Sponsors

Renovion, Inc., Matthew Bruehl

Conditions

Non-cystic Fibrosis BronchiectasisPre-Bronchiolitis Obliterans SyndromeTracheostomy

Phase 1

An Investigator-initiated Study to Evaluate Safety and Efficacy of ARINA-1 in People With a Tracheostomy

WithdrawnNCT05658029

Matthew BruehlTracheostomy

Start: 2023-05-23End: 2023-09-09Updated: 2024-05-14

Phase 2

Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough

CompletedNCT05495243

Renovion, Inc.Non-cystic Fibrosis Bronchiectasis

Start: 2022-10-03End: 2024-02-01Updated: 2025-07-23

Phase 3

Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

RecruitingNCT05654922

Renovion, Inc.Pre-Bronchiolitis Obliterans Syndrome

Start: 2023-04-10End: 2028-08-01Target: 100Updated: 2026-08-05